<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267718</url>
  </required_header>
  <id_info>
    <org_study_id>FADOI.04.2018</org_study_id>
    <nct_id>NCT04267718</nct_id>
  </id_info>
  <brief_title>Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients</brief_title>
  <acronym>RICO</acronym>
  <official_title>Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients: the RICO Cluster-randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fadoi Foundation, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fadoi Foundation, Italy</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      FADOI (Italian Scientific Society of Hospital Internal Medicine) has planned to promote a
      multicenter cluster-randomized controlled clinical study in order to evaluate the effects of
      a systematic assessment of patients by using the Padua prediction score and the IMPROVE
      Bleeding score vs clinical judgement on the use of antithrombotic prophylaxis and clinical
      outcomes (thromboembolic and hemorrhagic events).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most recent guidelines suggest the use of prophylaxis in patients with a high
      thromboembolic risk, while taking into account the risk of bleeding.

      It is known that patients admitted for acute pathology have an eight-fold higher incidence of
      thromboembolic events than the general population.

      The Padua Prediction Score (PPS) is currently considered the best score available for the
      evaluation of thromboembolic risk in hospitalized patients, while the IMPROVE score was
      developed and validated for the assessment of bleeding risk in the same population of
      hospitalized patients.

      In a recent study, data from the real world showed us how many of the patients admitted in
      Internal Medicine were at high thrombotic risk according to PPS and almost 90% of these were
      simultaneously at low hemorrhagic risk according to the IMPROVE score: in these patients
      pharmacological prophylaxis could therefore be prescribed during a safe stay.

      Until now only a small prospective monocentric quasi-randomized study has shown that the use
      of systematic PPS reduces the incidence of thromboembolic events (symptomatic and
      non-symptomatic) upon discharge, compared to clinical judgment alone.

      For these reasons, FADOI Foundation has promoted a multicenter controlled randomized cluster
      study in a real-life context among patients admitted to medical area departments. The aim of
      the study will be to analyze the effects of a systematic evaluation of patients (in centers
      that do not require the use of any score for the evaluation of thromboembolic risk), using
      the Padua Prediction Score (PPS) and the IMPROVE Bleeding score vs only clinical judgment for
      the use of antithrombotic prophylaxis and clinical outcomes (thromboembolic and haemorrhagic
      events). The main objective of the study is therefore to evaluate the effectiveness of a
      systematic evaluation of the thromboembolic and hemorrhagic risk in reducing the number of
      major complications in patients admitted to Internal Medicine, at a 90-day follow-up after
      hospital discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The experimental group includes a number of centres that will be randomized to systematically evaluate all eligible patients with the Padua and IMPROVE Bleeding scores within 48 h after hospitalization. The control group includes A number of centres will be randomized to the Control arm of the study, in which patients will be evaluated for their thrombotic and hemorrhagic risk according to clinical judgment only.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients with major complications at a 90-day follow-up</measure>
    <time_frame>3 month from the discharge</time_frame>
    <description>The percentage of patients with major complications (death, venous thromboembolism, major bleeding) at a 90-day follow-up in the group of patients who will be evaluated by means of the Padua and IMPROVE Bleeding scores vs those evaluated according to clinical judgment only</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcomes at hospital discharge</measure>
    <time_frame>Time of hospitalization until discharge, up to 5 weeks</time_frame>
    <description>The percentage of patients with major complications (death, venous thromboembolism, major bleeding) at hospital discharge in the group of patients who will be evaluated by means of the Padua and IMPROVE Bleeding scores vs those evaluated according to clinical judgment only</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with antithrombotic prophylaxis during hospital stay and at discharge.</measure>
    <time_frame>Time of hospitalization until discharge, up to 5 weeks</time_frame>
    <description>All the clinical characteristics of the patient collected, are compared between the experimental group and the clinical judgment group to understand the choice of an antithrombotic prophylaxis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2880</enrollment>
  <condition>Prevention of Venous Thromboembolism</condition>
  <arm_group>
    <arm_group_label>Patients with the Padua and IMPROVE Bleeding scores</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A number of centres will be randomized to systematically evaluate all eligible patients with the Padua and IMPROVE Bleeding scores within 48 h after hospitalization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients will be evaluated according to clinical judgment only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>A number of centres will be randomized to the Control arm of the study, in which patients will be evaluated for their thrombotic and hemorrhagic risk according to clinical judgment only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Application of Padua and IMPROVE Bleeding scores</intervention_name>
    <description>Eligible patients hospitalized in centres randomized to the Experimental group will be evaluated, within 48 hours from admission to hospital, by means of the Padua predictive score and the IMPROVE Bleeding score.</description>
    <arm_group_label>Patients with the Padua and IMPROVE Bleeding scores</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age â‰¥18 years

          2. Hospitalized for any cause in Internal Medicine

          3. Signature of informed consent

        Exclusion Criteria:

          1. Expected hospital stay &lt; 48 h

          2. Any indication for anticoagulant therapy

          3. Life expectancy &lt; 90 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Campanini</last_name>
    <role>Study Director</role>
    <affiliation>Fadoi Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Dentali</last_name>
    <phone>+390248005140</phone>
    <phone_ext>+390248005140</phone_ext>
    <email>francesco.dentali@asst-settelaghi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonella Valerio</last_name>
    <phone>+390248005140</phone>
    <phone_ext>+390248005140</phone_ext>
    <email>antonella.valerio@fadoi.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale di Casale Monferrato</name>
      <address>
        <city>Casale Monferrato</city>
        <state>Alessandria</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;SS Antonio e Margherita&quot;</name>
      <address>
        <city>Tortona</city>
        <state>Alessandria</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gian Mario Santamaria</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Senigallia</name>
      <address>
        <city>Senigallia</city>
        <state>Ancona</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laura Morbidoni</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Molfetta</name>
      <address>
        <city>Molfetta</city>
        <state>Bari</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Cosimo Damiano Ciannamea</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Marcianise</city>
        <state>Caserta</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicola Passariello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Ceva</name>
      <address>
        <city>Ceva</city>
        <state>Cuneo</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carlo Lorenzo Muzzulini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di MondovÃ¬</name>
      <address>
        <city>MondovÃ¬</city>
        <state>Cuneo</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Maria Gabriella Nallino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Osp. Casa Sollievo Della Sofferenza</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>Foggia</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonio Varriale</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Legnano</city>
        <state>Milano</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonino Mazzone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Magenta</name>
      <address>
        <city>Magenta</city>
        <state>Milano</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicola Mumoli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Media Valle del Tevere</name>
      <address>
        <city>Todi</city>
        <state>Perugia</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Maurizia Gambacorta</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Generale di Zona</name>
      <address>
        <city>Lagonegro</city>
        <state>Potenza</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Diodoro Coladurro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Marco</name>
      <address>
        <city>Grottaglie</city>
        <state>Taranto</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Maria Grazia Ruggero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Rivoli</name>
      <address>
        <city>Rivoli</city>
        <state>Torino</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberta Marcialis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giacomo Apostolo</name>
      <address>
        <city>Castelfranco Veneto</city>
        <state>Treviso</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Adriana VisonÃ </last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Conegliano Veneto</name>
      <address>
        <city>Conegliano</city>
        <state>Treviso</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Antonio Vendrame</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Luini Confalonieri&quot;</name>
      <address>
        <city>Luino</city>
        <state>Varese</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Francesco Dentali</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Borgosesia</name>
      <address>
        <city>Borgosesia</city>
        <state>Vercelli</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefano Dacquino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinal Massaia</name>
      <address>
        <city>Asti</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laura Massarelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Beato Angelo&quot;</name>
      <address>
        <city>Cosenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Maria Ferraro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Cremona</name>
      <address>
        <city>Cremona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matteo Giorgi Pierfranceschi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Croce di Fano</name>
      <address>
        <city>Fano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luciano Mucci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>E.O. Ospedali Galliera</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giancarlo Antonucci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore Niguarda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Francesca Agnelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera &quot;Cardarelli&quot;</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Chiara Mastrobuoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Fatebenefratelli</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luca Fontanella</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Silvestrini di Perugia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michela Giustozzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Pirro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Bianchi-Melacrino-Morelli&quot;</name>
      <address>
        <city>Reggio Calabria</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Francesco Condemi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;S. Giovanni Addolorata&quot;</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luca Morriconi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Vannini&quot;</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dario Martolini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;San Paolo&quot;</name>
      <address>
        <city>Savona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paola Gnerre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Treviso</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sabina Villalta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo &quot;Macchi&quot;</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrea Maresca</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eleonora Nicolini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Andrea</name>
      <address>
        <city>Vercelli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberta Terribile</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;S. Bortolo&quot;</name>
      <address>
        <city>Vicenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giovanni Scanelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

